Literature DB >> 15505762

Population-based measurement of quality of diabetes care using HbA1c values in the state of Thuringia/Germany.

A Sämann1, J Kaiser, W Hunger-Dathe, R Schiel, U A Müller.   

Abstract

INTRODUCTION/HYPOTHESIS: There remains insufficient knowledge about the quality of diabetes therapy regarding structure, process and outcome given by primary care in Thuringia, and elsewhere in Germany. The project assesses a means of determining the quality of diabetes therapy in primary care by analysis of HbA1c values within a broad territory.
METHODS: HbA1c tests of Thuringian patients were analysed by 20 participating medical laboratories between January 1 and March 31, 2002; each HbA1c test was identified by the postal code of the Thuringian General Practitioner (GP) who ordered the test and adjusted by a standardisation procedure (mean normal of healthy subjects 5 %). The German state of Thuringia (population of 2,421,871) consists of 23 urban and rural districts. This format was also used in the present study.
RESULTS: Twenty participating laboratories contributed 59,702 HbA1c tests from diabetic patients in Thuringia. Adjusted mean HbA1c of entire Thuringia: 6.75 %, 36.4 % of all HbA1c tests were above 7.0 % and 3,0 % of all HbA1c values above 10.0 %. Regional percentage of HbA1c tests above 7.0 % ranged between 28.2 % and 47.3 %. Regional percentage of HbA1c tests above 10.0 % ranged between 1.8 % and 4.8 %. Subgroup analyses comparing urban vs. rural districts showed significantly lower mean HbA1c (6.72 % vs. 6.75 %, CI 0.01 - 0.06, p < 0.01) and percentage of HbA1c tests above 7 % (8.19 % vs. 8.24 %, CI 0.01 - 0.08, p < 0.01) in urban areas.
CONCLUSIONS: Mean HbA1c as an indicator of glycaemic control of diabetes patients in primary care in Thuringia was good. The percentage of patients who need immediate medical intervention to prevent acute complications varied between districts, which is indicative for differences in quality of diabetes care in Thuringia. However, the proposed method is still experimental and has not yet been evaluated. Consequently, considerable bias might influence the results.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505762     DOI: 10.1055/s-2004-821311

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  4 in total

1.  [Prevalence of diabetic retinopathy. Check-up program of a public health insurance company in Germany 2002-2004].

Authors:  M Blum; C Kloos; N Müller; A Mandecka; R Berner; B Bertram; U A Müller
Journal:  Ophthalmologe       Date:  2007-06       Impact factor: 1.059

2.  Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study.

Authors:  Margaret A Stone; Guillaume Charpentier; Kris Doggen; Oliver Kuss; Ulf Lindblad; Christiane Kellner; John Nolan; Agnieszka Pazderska; Guy Rutten; Marina Trento; Kamlesh Khunti
Journal:  Diabetes Care       Date:  2013-04-29       Impact factor: 19.112

3.  Metabolic control in a nationally representative diabetic elderly sample in Costa Rica: patients at community health centers vs. patients at other health care settings.

Authors:  Gilbert Brenes-Camacho; Luis Rosero-Bixby
Journal:  BMC Int Health Hum Rights       Date:  2008-05-14

4.  Sociodemographic patterning of long-term diabetes mellitus control following Japan's 3.11 triple disaster: a retrospective cohort study.

Authors:  Claire Leppold; Masaharu Tsubokura; Akihiko Ozaki; Shuhei Nomura; Yuki Shimada; Tomohiro Morita; Sae Ochi; Tetsuya Tanimoto; Masahiro Kami; Yukio Kanazawa; Tomoyoshi Oikawa; Sarah Hill
Journal:  BMJ Open       Date:  2016-07-07       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.